AN2 Therapeutics, Inc.

8-K Shareholder vote results Jun 9, 2026 8-K Regulation FD disclosure; Other events Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 8-K Other events Apr 9, 2026 8-K Director or officer change Mar 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 17, 2026 8-K Results of operations (earnings release) Mar 17, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Mar 10, 2026 8-K Director or officer change Jan 29, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Aug 12, 2025 8-K Unregistered sale of equity Jun 20, 2025 8-K Regulation FD disclosure Jun 11, 2025 8-K Shareholder vote results May 27, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K May 13, 2025 8-K Regulation FD disclosure May 1, 2025 10-K Fiscal year ended 2024-12-31 Mar 25, 2025 8-K Results of operations (earnings release) Mar 25, 2025 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Director or officer change Nov 5, 2024 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws Aug 19, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Exit or disposal costs; Director or officer change; Regulation FD disclosure; Other events Aug 8, 2024 8-K Shareholder vote results Jun 24, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) May 14, 2024 10-K/A Fiscal year ended 2023-12-31 May 14, 2024 10-K Fiscal year ended 2023-12-31 Mar 29, 2024 8-K Results of operations (earnings release) Mar 28, 2024 8-K Other events Feb 12, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023 8-K Other events Sep 13, 2023 8-K Director or officer change Sep 8, 2023